DO Dow Jones Newswires Replimune 4Q Loss $73.7M >REPL 6/29/2026, 08:04 PM GMT+8 Dow Jones Newswires RE REPL Sources Dow Jones Newswires Markets Stocks Active symbols NASDAQ:REPL Language English Replimune 4Q Loss $73.7M >REPL Market News Stocktwits FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions Dow Jones Newswires Replimune Group Is Maintained at Neutral by Wedbush TradingView Replimune Group, Inc. Stock 12‑Month Price Target Raised to $8.17, Implies 30% Downside Reuters Replimune Group Inc reports results for the quarter ended March 31 - Earnings Summary
